Join
Live feed
·
INSIDERFilingvia Quantisnow
Arcutis Biotherapeutics Inc. logo

Director Gilbert Halley E exercised 12,220 shares at a strike of $7.51 and sold $455,442 worth of shares (16,532 units at $27.55), decreasing direct ownership by 16% to 22,123 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARQT (Arcutis Biotherapeutics Inc.) and more on Quantisnow.